{"id":"https://openalex.org/W4393854435","doi":"https://doi.org/10.1158/2767-9764.c.7162922","title":"Data from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate","display_name":"Data from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate","publication_year":2024,"publication_date":"2024-04-03","ids":{"openalex":"https://openalex.org/W4393854435","doi":"https://doi.org/10.1158/2767-9764.c.7162922"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.c.7162922","doi":"https://doi.org/10.1158/2767-9764.c.7162922","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7162922","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.c.7162922","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025507328","display_name":"Priyanka Hirani","orcid":"https://orcid.org/0000-0002-1347-5668","observed_orcids":["https://orcid.org/0000-0002-1347-5668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priyanka Hirani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1347-5668","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078730275","display_name":"Jacqueline R. McDermott","orcid":"https://orcid.org/0000-0001-8052-7133","observed_orcids":["https://orcid.org/0000-0001-8052-7133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacqueline McDermott","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8052-7133","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052560631","display_name":"Vinothini Rajeeve","orcid":"https://orcid.org/0000-0002-6361-4291","observed_orcids":["https://orcid.org/0000-0002-6361-4291"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinothini Rajeeve","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6361-4291","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046510449","display_name":"Pedro R. Cutillas","orcid":"https://orcid.org/0000-0002-3426-2274","observed_orcids":["https://orcid.org/0000-0002-3426-2274","https://orcid.org/0000-0002-4207-9349"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro R. Cutillas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3426-2274","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076743192","display_name":"J. Louise Jones","orcid":"https://orcid.org/0000-0003-3880-3274","observed_orcids":["https://orcid.org/0000-0003-3880-3274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Louise Jones","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3880-3274","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081521025","display_name":"Daniel J. Pennington","orcid":"https://orcid.org/0000-0001-7889-9923","observed_orcids":["https://orcid.org/0000-0001-7889-9923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Pennington","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7889-9923","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035268339","display_name":"Thomas N. Wight","orcid":"https://orcid.org/0000-0002-2794-4197","observed_orcids":["https://orcid.org/0000-0002-2794-4197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas N. Wight","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2794-4197","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053001744","display_name":"Salvatore Santamaria","orcid":"https://orcid.org/0000-0001-8670-7776","observed_orcids":["https://orcid.org/0000-0001-8670-7776"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Salvatore Santamaria","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8670-7776","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004026163","display_name":"Kimberly M. Alonge","orcid":"https://orcid.org/0000-0002-2171-1640","observed_orcids":["https://orcid.org/0000-0002-2171-1640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly M. Alonge","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2171-1640","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018077287","display_name":"Oliver M.T. Pearce","orcid":"https://orcid.org/0000-0003-3953-1629","observed_orcids":["https://orcid.org/0000-0003-3953-1629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver M.T. Pearce","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3953-1629","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/versican","display_name":"versican","score":0.9900000095367432},{"id":"https://openalex.org/keywords/chondroitin-sulfate","display_name":"chondroitin sulfate","score":0.9679999947547913},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.8949999809265137},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8050000071525574},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.6359999775886536},{"id":"https://openalex.org/keywords/glycosaminoglycans","display_name":"glycosaminoglycans","score":0.8220000267028809},{"id":"https://openalex.org/keywords/proteoglycans","display_name":"proteoglycans","score":0.8799999952316284},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9190000295639038},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.718999981880188},{"id":"https://openalex.org/keywords/tumor-stroma","display_name":"tumor stroma","score":0.5950000286102295},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C159470946","wikidata":"https://www.wikidata.org/wiki/Q14888030","display_name":"Versican","level":4,"score":0.8745927810668945},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6645443439483643},{"id":"https://openalex.org/C2779553658","wikidata":"https://www.wikidata.org/wiki/Q408014","display_name":"Chondroitin sulfate","level":3,"score":0.5510426759719849},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.5491294860839844},{"id":"https://openalex.org/C2775895372","wikidata":"https://www.wikidata.org/wiki/Q5104536","display_name":"Chondroitin sulfate proteoglycan","level":4,"score":0.47095710039138794},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4459713101387024},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3766663670539856},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3409907817840576},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28922975063323975},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27603617310523987},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22752144932746887},{"id":"https://openalex.org/C2779335624","wikidata":"https://www.wikidata.org/wiki/Q407976","display_name":"Proteoglycan","level":3,"score":0.19770526885986328},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16478756070137024},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.11291912198066711},{"id":"https://openalex.org/C153074725","wikidata":"https://www.wikidata.org/wiki/Q407553","display_name":"Glycosaminoglycan","level":2,"score":0.09156429767608643}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.c.7162922","doi":"https://doi.org/10.1158/2767-9764.c.7162922","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7162922","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.c.7162922","doi":"https://doi.org/10.1158/2767-9764.c.7162922","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.c.7162922","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393071030","https://openalex.org/W6982598906","https://openalex.org/W4362594269","https://openalex.org/W4393898988","https://openalex.org/W4409819006","https://openalex.org/W3029606313","https://openalex.org/W4393898941","https://openalex.org/W7127045446","https://openalex.org/W7056394646","https://openalex.org/W4393870843"],"abstract_inverted_index":{"Abstract":[0],"Immunotherapies":[1],"for":[2],"cancers":[3],"of":[4,14,19,26,43,60,83,108,125,131,137,140,156,170,175,204,214,223],"epithelial":[5],"origin":[6],"have":[7,162,262],"limited":[8],"efficacy,":[9],"and":[10,50,76,98,143,173,207,257,265],"a":[11,27,81,100,105,211,273],"growing":[12],"body":[13],"evidence":[15],"links":[16],"the":[17,24,41,109,123,128,135,144,149,154,176,197,202,215,221,243,255],"composition":[18,97],"extracellular":[20],"matrix":[21],"(ECM)":[22],"with":[23,54,95,119,122,250],"likelihood":[25],"favorable":[28],"response":[29,224,229],"to":[30,47,225,230],"treatment.":[31],"The":[32,228,245],"ECM":[33,58,96,216,246],"may":[34,72],"be":[35],"considered":[36],"an":[37],"immunologic":[38,62,110,217],"barrier,":[39],"restricting":[40],"localization":[42],"cytotoxic":[44],"immune":[45,239],"cells":[46,240],"stromal":[48],"areas":[49],"inhibiting":[51,169],"their":[52],"contact":[53,94,118],"tumor":[55,93,120,198,256],"cells.":[56],"Identifying":[57],"components":[59],"this":[61,259],"barrier":[63,218],"could":[64],"provide":[65],"targets":[66],"that":[67,115,147,187,208,219],"whether":[68],"degraded":[69],"in":[70,258,276],"situ":[71],"support":[73,191],"antitumor":[74],"immunity":[75],"improve":[77],"immunotherapy":[78,231],"response.":[79],"Using":[80],"library":[82],"primary":[84],"triple-negative":[85],"breast":[86],"cancer":[87],"tissues,":[88],"we":[89,185,261],"correlated":[90],"CD8+":[91,116],"T-cell":[92,117,171,182,194,252,277],"identified":[99,263],"proteoglycan,":[101],"versican":[102],"(VCAN),":[103],"as":[104,271],"putative":[106],"member":[107],"barrier.":[111],"Our":[112],"analysis":[113],"reveals":[114],"associates":[121],"location":[124],"VCAN":[126,132,161,188,209,264],"expression,":[127],"specific":[129],"glycovariant":[130],"[defined":[133],"through":[134],"pattern":[136,203],"posttranslational":[138],"attachments":[139],"glycosaminoglycans":[141],"(GAG)],":[142],"cell":[145],"types":[146],"produce":[148],"variant.":[150],"In":[151],"functional":[152],"studies,":[153],"isomers":[155],"chondroitin":[157,269],"sulfate":[158,270],"presented":[159],"on":[160,181,201],"opposing":[163],"roles":[164],"being":[165],"either":[166,190],"supportive":[167],"or":[168,192],"trafficking,":[172],"removal":[174],"GAGs":[177,205],"ameliorates":[178],"these":[179],"effects":[180],"trafficking.":[183],"Overall,":[184],"conclude":[186],"can":[189],"inhibit":[193],"trafficking":[195],"within":[196],"microenvironment":[199],"depending":[200],"present,":[206],"is":[210],"major":[212],"component":[213],"defines":[220],"type":[222],"immunotherapy.":[226],"Significance:":[227],"has":[232,247],"been":[233,248],"poor":[234],"toward":[235,254],"solid":[236],"tumors":[237],"despite":[238],"infiltrating":[241],"into":[242],"tumor.":[244],"associated":[249],"impacting":[251],"infiltration":[253],"article":[260],"its":[266],"structural":[267],"modification,":[268],"having":[272],"key":[274],"role":[275],"invasion.":[278]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2024-04-04T00:00:00"}